TG Therapeutics | TGTX - صافي الدخل





صافي الدخل تغيير تاريخ
AbbVie USD 3.61B 2.92B 2026-06
Alaunos Therapeutics USD -1.01M 153K 2026-03
Amgen USD 2.38B 556M 2026-06
Ardelyx USD -37.6M 37.2M 2026-03
Arrowhead Research USD -132.73M 163.54M 2026-03
Bayer EUR 2.76B 6.52B 2026-03
Biogen USD 97.5M 222M 2026-06
Corcept Therapeutics USD 42.14M 73.9M 2026-06
Curis USD -24.2M 43.56M 2026-03
Gilead Sciences USD -10.5B 12.52B 2026-06
J&J USD 5.53B 299M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Novartis USD 3.26B 108M 2026-06
Novavax USD 17.53M 219.91M 2025-12
PTC Therapeutics USD -2.81M 132.16M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
TG Therapeutics USD 7.78M 12M 2026-06
Verastem USD -36.59M 3.68M 2026-03
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06